An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes.
about
Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysisBone marrow derived stem cells for the treatment of end-stage liver diseaseAutologous bone marrow-derived cells in the treatment of liver disease patientsConcise review: bone marrow autotransplants for liver disease?Stem cell differentiation and human liver diseaseSupportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionImproved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapyAn uncomfortable silence em leader while we all search for a better reporter gene in adult stem cell biology.Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression.Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation.Amniotic epithelial cell-derived cholangiocytes in experimental cholestatic ductal hyperplasia.Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorTransplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral strokeEnhanced expression of fibroblast growth factor 2 in bone marrow cells and its potential role in the differentiation of hepatic epithelial stem-like cells into the hepatocyte lineage.Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated miceOutcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion.Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?Granulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice.Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues.Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy.The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulationThe role of glucose, serum, and three-dimensional cell culture on the metabolism of bone marrow-derived mesenchymal stem cells.Autologous bone marrow stem cells in the treatment of chronic liver diseaseHepatic stem cells: from inside and outside the liver?CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in miceDevelopment of cell therapy using autologous bone marrow cells for liver cirrhosis.Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.Stem cells for liver tissue repair: current knowledge and perspectivesTherapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches.Stem cells for end stage liver disease: how far have we got?Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine.Bone marrow cell-based regenerative therapy for liver cirrhosis.Could Stem Cell Therapy be the Cure in Liver Cirrhosis?Cell transplantation as a non-invasive strategy for treating liver fibrosis.Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
P2860
Q26801163-3C349BB8-B4E4-4DDD-A450-C1C16A96B5F8Q26850412-D16D9C66-4C98-4F1E-9F47-A849F058208CQ26863284-406BF26B-B989-4F8C-A08D-0C8B980CE5D7Q27010009-24400183-4FDB-4B5D-B72B-5A674F614E7BQ27027529-1F965872-DD52-43A2-8770-84686FA2FADFQ28066295-2E8F8737-1CC3-4B33-9F40-40E36F6AC105Q28246439-38FD0A8A-4397-4F7F-B4B1-50BC50FD4416Q33200725-2092619D-74CE-46D4-A2C9-B3925FEB1EE2Q33209609-C914016F-7863-4620-8557-365B70944A28Q33225247-095DD2E1-5670-40F9-84FE-AC500212DEF4Q33237026-4792E97E-ECF8-4959-9245-A9543770DB99Q33280647-71BD841B-DA8C-4D21-8D5A-32110289B8DDQ33629414-45F7BC63-E0D6-46EC-939E-B45EBCC5EF79Q33727333-38E9D804-3043-4672-BA02-77DF8831FACEQ33770430-10A898C4-23D9-43D1-83B9-92859C36755BQ33787709-94D5D721-F1A0-44B7-BC94-6C4BB990129DQ33887116-22C9CE90-2AAD-4878-9767-43EA223AA398Q34045941-FB898409-8CCB-49BB-A315-D65A5507977BQ34203516-18451574-1107-4C53-AAE4-37ED20F0B8ACQ34234307-99EDA2CE-7AD7-49DA-9F6A-FEFA0123FD20Q34400554-0F97FDB8-AB11-4E69-9152-EAE2663A811DQ34431366-B0C69D5C-D534-4CE0-952E-1D80A7D498FCQ34480369-70AA7914-769B-40B9-8101-95EB39D52314Q34535502-A8C2AD95-9D71-44FB-B271-ACF1577CD67EQ34986559-021CA3CB-0EA2-4A97-A32D-8566560A8B57Q35550572-54850E32-4B84-4968-9C32-356AD900B3E0Q35660987-514B055E-833C-433E-9F77-5031F20E9F76Q36188234-36D36C4B-F162-4D78-92D2-114BC8DF6CF7Q36353752-B65B1F9F-9619-4FBD-AE7D-3FBFA8FA079DQ36736835-172A45BA-0E3A-453B-AD5E-FED19CE02787Q37073810-608A9C81-19A0-42DC-AA47-8670B751CE03Q37164150-6C2A976C-52FC-4243-9205-4DA4ABEA21B9Q37242563-AAE0D250-1156-4E9F-8573-B05C04703EAEQ38001330-DB4F9140-83B9-47BD-AB9D-E58B894EE678Q38108630-9121DC2B-B597-4890-9D1A-1024F5606BDFQ38167714-85CA2A62-C998-405E-B8F2-A932A78FD153Q38252582-F584A04E-FE3F-4FF8-A7AF-97EFDB6F7061Q38544019-255B834F-6374-47FE-B988-B4FB1C2D7953Q38675565-859A7DFE-B367-4E74-B2D9-9B2B350C0FE9Q39000508-98DDC5B8-AF1F-4306-B322-A91D2913D2BA
P2860
An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
An in vivo model for monitorin ...... s into functional hepatocytes.
@ast
An in vivo model for monitorin ...... s into functional hepatocytes.
@en
type
label
An in vivo model for monitorin ...... s into functional hepatocytes.
@ast
An in vivo model for monitorin ...... s into functional hepatocytes.
@en
prefLabel
An in vivo model for monitorin ...... s into functional hepatocytes.
@ast
An in vivo model for monitorin ...... s into functional hepatocytes.
@en
P2093
P356
P1476
An in vivo model for monitorin ...... s into functional hepatocytes.
@en
P2093
Hiroshi Nishina
Isao Sakaida
Kaoru Omori
Kiwamu Okita
Koh Shinoda
Koji Miyamoto
Naoki Yamamoto
Shinya Ohata
Shuji Terai
Tomomi Watanabe
P304
P356
10.1093/JB/MVG173
P577
2003-10-01T00:00:00Z